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Biomonitoring Exposure to Metal Compounds
with Carcinogenic Properties
by Alain Leonard1 and Alfred Bernard2
Several metals such asarsenic,beryllium,chromium andnickel arecarcinogenictomanwhentheyoccurin
certain well-defined physicochemical forms. The carcinogenic potential of these metals is linked to their
mutagenicproperties.Thedetermination ofthemetal orpossiblyofitsmetabolites inbiological mediaandthe
cytogenetic examination ofsomatic cells are two methods that can currently be used to monitor exposure of
populations at risk. Due tothe use ofinappropriate methodology, thevalue ofthe positive cytogenetic results
published so far appears questionable. By contrast, the concentrations of metals in blood, urine, or other
biologicalmaterialscanbedeterminedwithaccurate andprecisemethods.Althoughitdoesnotpermitadirect
assessment of the carcinogenic risk, this approach is currently the most suitable for monitoring exposed
populations.
Carcinogenicity and Mutagenicity of
Metal Salts
There is clear evidence that arsenic, beryllium, chro-
mium, and nickel, when present in certain well defined
physicochemical forms,represent acarcinogenichazardto
man. Earlier observations of cadmium carcinogenicity
were not sustained by the recent updates of cohorts. To
varying degrees, the epidemiological findings have been
duplicated by positive results in laboratory animals but, if
weexceptthe caseofarsenic,metal carcinogenesis is not a
problemofenvironmental contamination attracelevels but
is relevant to occupational medicine (1).
From the results of the several hundreds short-term
tests performed to assess the carcinogenic properties of
metal salts on the basis of mutagenicity (2), it can be
concluded that there is a clear relationship between the
carcinogenic potential of a metal compound and its gen-
otoxicity. It is evident, however, that a number of assays
such as the Ames' test on Salmonella typhimurium are
not appropriate for assessing the carcinogenicity ofmet-
als (3). Itismainly onthebasis ofnegative results obtained
withthis assaythatit wasinferred thatmetal carcinogens
actbynongenotoxicmechanisms. Recently, however, ithas
been shownthat somemutagenic substances do notinduce
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significant reversion in the Ames test, although they pro-
duce forward mutations in mammalian somatic cells or in
somebacteria,i.e.,resistancetoantibioticsorotherdetect-
able mutations that can be positively selected.
Asfarasmechanisms areconcerned,forwardmutations
may be caused by unrepaired or unrepairable insertions,
deletions, rearrangements, orpointmutations that are not
detectableintheAmestest. Inthatrespect,itisofinterest
to point out that the fluctuation assay is a more sensitive
technique than the plate incorporation assay. This illus-
trates the importance of choosing a method appropriate
forhighlytoxicsubstances. Theseassayshavealsodemon-
strated that the response obtained depends on the ability
ofthemetaltopenetratethecellandtointeractwithDNA,
the chemical speciation, the physical properties [oxidation
state, e.g., Cr(VI) and Cr(III), As(V), andAs(III); charge,
solubility, crystal form, properties of ligands, complex
stereochemistry] and the possible interactions with other
xenobiotics are, in that respect, critical. Metals such as
Ni(II) or Cd(II) may be precipitated as insoluble phos-
phate salts due to orthophosphate ions present in the
normal bacteriological culture medium and, for this rea-
son, may not be detected as mutagenic. Some of the
variation observed intheresults ofthebioassays ofdiffer-
ent metal salts could, therefore, be due to differences in
bioavailability rather than in genotoxic potential (4).
The relation observed between the carcinogenicity of
some metal compounds and their genotoxic potential does
not exclude the possibility of additional mechanisms.
Development of tumors is a multistep process in which
initiation must usually be followed by various factors
promoting growth of the transformed cells. Beside their
general cytotoxic action causing denaturation of macro-
molecules, several metals may alter the fidelity of tran-LEONARD AND BERNARD
scription by DNA polymerase (5), produce apurinic inter-
mediates (6), orcompetewith an essential metal needed to
stabilizethestructureofabiomolecule. B-DNA,theclassi-
cal Watson-Crick double helix, contains 10 residues per
turn,whereas Z-DNA, aleft-handed doubleform ofDNA,
contains about 12 residues per turn (7). Some metal salts
such as Ni(II) have been shown to induce conformational
transitionofB-DNAtoZ-DNA,whichismoresensitivefor
the induction ofmutations by some chemicals (8). Several
compounds, such as inorganic soluble arsenic salts can
inhibit the repair ofDNA damage (9). Other mechanisms
could also play a role, such as blocking of cell-to-cell
communication, stimulation oflipidperoxidation (10), solid-
state carcinogenesis (11), inflammation and chronic
mitogenesis increasing the probability of converting
endogenous DNA damage into mutations (12), increasing
intracellular radicals, interacting with detoxification
mechanisms, catalyzing redox reactions, interfering with
respiratory chains, increasing DNA alkylation by ubiq-
uitous carcinogens affecting spindle apparatus, or
destroying cellular homeostasis (13).
Biomonitoring People Exposed to
Carcinogenic Metals
Methods currently available for the biological monitor-
ing of populations exposed to mutagenic or carcinogenic
chemicals evaluatethe exposure to genotoxic chemicals by
measuring their concentration in body fluids, by estimat-
ing the amount of compound bound to target mac-
romolecules (DNA), or by detecting various genotoxicity
end points or early signs of neoplasia. The majority of
these tests are, however, under development, and only
three maybe considered for routine biomonitoring: deter-
mination of the chemical or its metabolites in biological
media, determination of the mutagenic activity in biolog-
ical materials, and cytogenetic observations on somatic
cells. Mutagenic activity is generally detected by the
Ames' testperformed onurine. Becausethis testhas been
found to be inappropriate to detect the mutagenicity of
metal compounds, the monitoring of people exposed to
metal salts is generally restricted to the determination of
the chemical in biological media and to cytogenetic anal-
ysis on peripheral blood lymphocytes.
Arsenic
Humansmaybeexposedtodifferentarseniccompounds
which markedly differ in their chemical and toxicological
properties. Inindustry andin areaswhere drinkingwater
is contaminated by arsenic, humans are exposed to
inorganic arsenic, whichmaycause cancers oftherespira-
tory tract (byinhalation) orthe skin (byingestion). In the
humans, inorganic arsenic is methylated into two metabo-
lites that are more readily excreted in urine: mono-
methylarsonic acid (MMA) and dimethylarsinic acid
[DMA or cacodylic acid (14,15)]. High amounts of arsenic
mayalsobyabsorbed through the consumption offish and
other marine organisms. Seafood, however, contains
essentially organic derivatives of arsenic (e.g., arsenobe-
taine), which display a negligible toxicity and are rapidly
excreted without further biotransformation.
Determination ofArsenic and Its Metabolites. The
biological method currently used for monitoring arsenic
exposureinindustryreliesonthedeterminationofurinary
arsenic with a speciation between organic and inorganic
arsenic, MMA and DMA, to avoid the interference of
arsenic from seafood. The total urinary excretion of
inorganic arsenic and its metabolites is normallybelow 10
,ug/g creatinine (16). The determination of total arsenic
concentration in urine (without speciation) can be consid-
ered for monitoring exposure to inorganic arsenic only if
the subject has been instructed to refrain from eating
seafood 2 or 3 days before urine collection. The arsenic
level in blood does not seem to be a reliable indicator of
chronic arsenic exposure (17).
Because of their high content in sulfhydryl groups
(keratin), nails and hair can accumulate inorganic arsenic
butnotoronlyto a small extent canthesetissues accumu-
late the methylated metabolites ofarsenic or arsenic from
marine origin. In contrast to urinary orbloodborne arse-
nic, which reflects mainly recent exposure, hair and nails
allowintegration ofthe arsenic exposure overtheirperiod
ofgrowth. The concentration ofarsenic in hair or nails is
normallybelow1-2ppm(16).Asegmentalanalysisofthese
materialsmayevenprovideinformation onthe sequenceof
exposure episodes. The problem ofhair or nail analysis is,
however, to differentiate endogenous arsenic from arsenic
adhering to the external surface (18).
Cytogenetic Observations on Somatic Cells. Arseni-
cals have been shown to be powerful clastogens in experi-
ments performed in vitro on different mammalian cell
types, and slightly positive results have been obtained in
vivoinlaboratoryanimals. Inhumans, no clearevidenceof
clastogenicity has been produced so far, despite the
numerous cytogenetic studies carried out on highly
exposed populations. The latter included patients treated
with arsenic, wine growers contaminated by arsenic-
containing pesticides, and workers exposed to airborne
arsenic at the Ronnskar copper smelter in Northern Swe-
den (19-22).
Most ofthese studies have been performed on lympho-
cytes culturedfor72hr. Thenumberofcellsexaminedwas
small (generally 100), and gaps contributed greatly to the
increase of structural aberrations. In the smelters, the
yield ofstructural aberrations was significantlyincreased
compared to the controls, but the correlation between the
frequencyofaberrations and arsenic exposure was rather
poor except for chromosome-type aberrations. Because in
smelters theworkerswere generallyexposed to amixture
ofpossible mutagens, the authors suggested that the role
of arsenic was only to inhibit the repair of damage pro-
duced by other environmental agents (19-22). Observa-
tions on patients treated with arsenic could clarify the
situation because doses are still higher and fewer pos-
sibilitiesofinterferencewithothermutagenicagentsexist.
Petres et al. (23) and Nordenson et al. (24) reported a
significant increase of aberrations in these persons, but
this was not confirmed by Burgdorf et al. (26), in spite of
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the factthat some patients received, in addition to arsenic,
local irradiation doses as high as 50 Gy.
A similar contradiction appears in the ability ofarsenic
toincreasetheyield ofsisterchromatid exchanges (SCEs)
invivo in human peripheral blood lymphocytes: Burgdorf
et al. (25) found a 3-fold increase of SCEs in six patients
treated with arsenic, whereas the SCE rate was normalin
both arsenic-treated and untreated patients examined by
Nordenson etal. (24). Itshouldberecalled that anincrease
of SCEs has been obtained in vitro with all the arsenic
salts tested up to now (26).
Beryllium
Numerous epidemiological studies suggest an increase
of respiratory cancers among persons occcupationally
exposed to beryllium. The carcinogenic activity of beryl-
lium, whether administered in the form of the metal,
alloys, or other organometallic compounds, has been con-
firmed in a number ofexperiments on laboratory animals.
Determination ofBeryllium. Data on the toxicokine-
tics of beryllium in humans are insufficient to propose a
reliable method forthe biomonitoring ofthis metal. Beryl-
lium can be measured in blood and urine, but it is not
known to what extent the concentration of beryllium in
these fluids relates to recent or past exposure. Observa-
tions on newly exposed workers suggest that beryllium in
urine maybe a reflection ofthe current exposure (27), but
it has also been reported that the urinary excretion of
beryllium mayremain elevated several years afterthe end
ofexposure (28,29). In personsnonoccupationallyexposed,
the mean concentration ofberyllium in urine and blood is
around 1 ,ug/L (27).
Cytogenetic Observations on Somatic Cells. As far as
we know, no cytogenetic study has been reported on
workers exposed to beryllium.
Cadmium
Cadmium is efficiently retained by humans: it accumu-
lates with abiological half-life of10-30 years. The highest
cadmium concentrations are found in the kidneys, which
can account for more than 50% of the cadmium body
burden at environmental exposure levels (16).
The carcinogenicity ofcadmium for human is currently
a much debated question. Earlier suspicion that exposure
to cadmiumcompounds, primarlycadmium oxide, couldbe
a factor in prostatic cancer, genito-urinary cancers, and
gastric cancer has not been sustained by updates of the
cohorts (30). The case for implicating cadmium in the
induction of lung cancer has also been greatly weakened
by a reappraisal of the data taking into account the
possible confounding with exposure to arsenic (30).
Determination ofCadmium. The cadmium body bur-
den may be directly estimated by a neutron activation
technique (31). This noninvasive method which has been
used to assess the critical level ofcadmium in the human
renal cortex (32,33), but it is not suitable to a routine
application. The biomonitoring of populations exposed to
cadmium in the work or general environment relies on
determining the metal in blood and urine. The concentra-
tion of cadmium in urine is mainly a reflection of the
cadmium body burden. In the general population exposed
to cadmium via contaminated diet or by tabacco smoking,
theurinaryexcretionofcadmiumincreases onthe average
with age to a maximal value reached between 50 and 60
years of age. In workers occupationally exposed to cad-
mium, the urinary excretion of the metal also increases
with the duration of exposure in parallel with the body
burden. There are, however, two situations in which uri-
nary cadmium no more reliably mirrors the body burden:
a) when the cadmium binding capacity ofthe organism is
saturated, which may occur after acute orprolonged expo-
sure to high levels ofcadmium, and b) when the ability of
proximal tubule cell to reabsorb cadmium and to store itis
compromisedbythe occurrence ofrenallesions (34). Inthe
absence of occupational exposure, the concentrations of
cadmium in blood and urine are normally below 5 pLg/L
and 2 ,ug/g creatinine, respectively (Table 1).
Exposureto cadmium can alsobemonitoredby measur-
ing the urinary excretion of metallothionein. The con-
centration of metallothionein in urine goes hand in hand
Table 1. Biological methods for monitoring exposure to metals with established or suspected carcinogenicity (16).
Biological Biological Tentative maximum
Metal parameter material Normal value permissible value Remarks
Arsenic Total As Urine < 40 p.g creatinine Interference from
fish consumption
Total As Hair < 1 ,ug/g
Inorganic As and Urine < 20 p.g/g creatinine < 50 p.g/g creatinine No interference
its metabolites (TLV: 50 ,ug/m3) from fish
consumption
< 30 ,ug/g creatinine
(TLV: 10,g/m3)
Beryllium Be Urine < 2 .g/g creatinine Nonsmokers
Cadmium Cd Urine < 2 p.g/g creatinine 5 ,ug/g creatinine
Cd Blood < 0.2 Rg/1O0 mL 0.5 ,ug/100 mL
Metallothionein Urine
Chromium (soluble Cr Urine < 5 ,ug/g creatinine 30 ,ug/g creatinine
compounds)
Nickel (soluble Ni Urine < 2 p.g/g creatinine 30 ,ug/g creatinine
compounds) Ni Plasma < 0.05 ,ug/10O mL 1 ,ug/100 mL
TLV, threshold limit value.
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with that of cadmium, regardless the status of renal
function and the intensity of cadmium exposure. The
advantage ofmetallothionein is thatitis notinfluencedby
the external contamination -a problem frequently
encountered when monitoring trace metals in biological
fluids (35).
Increased levels ofcadmium have been reported in hair
samples frompersons occupationallyexposed to cadmium
orlivinginthevicinity ofcadmiumindustries (36,37). The
difficulty with hair analysis is to distinguish endogenous
cadmium from external contamination. Furthermore, itis
unlikely that the concentration of cadmium in hair is
related with that in the main target organs (kidney or
lung).
During exposure to cadmium, the blood cadmium con-
centrationismainlyanindicatoroftheintake overthelast
few months (i.e., of the recent exposure) (34). In persons
with previous high exposure (e.g., retired workers) the con-
centration ofcadmium inbloodmaybepredominantlyinflu-
encedbythebodyburdeniftheamountofcadmiumreleased
from storage sites exceeds that currently absorbed.
Cytogenetic Observations on Somatic Cells. The
majority ofthe assays performed in vitro and in vivo to
evaluate the clastogenic properties of cadmium salts in
mammaliancellsyieldednegativeresults (38),andthiswas
confirmed by Bui et al. (39) on Itai-Itai patients and male
workers from an alkaline battery factory and by O'Rior-
danetal. (40)onapopulationemployedinthemanufacture
of cadmium pigments. In both studies none of the indi-
viduals had received radiotherapy or drugs known to
produce chromosome damage. The cadmiumblood level at
the time ofthe cytogenetic observations were 1.95 pug/100
mL versus 0.2 p,g/100 mL in the controls in the group
studied byO'Riordan et al. (40) and, in the studyofBui et
al. (39), rangedfrom24.7to 61.0ng/gand from 15.5to 28.8
ng/g for the industrial workers and the Itai-Itai patients,
respectively.
Positive results were reported by several authors who
studied workers exposed to cadmium in zinc smelting
plants (41-44) orJapanese Itai-Itaipatients (45,46). Inthe
studies on industrial workers, the cadmium content of
blood did not differ greatly from the values reported by
O'Riordan etal. (40), and nocorrelation wasfoundwiththe
degree ofexposure. Furthermore, it should bepointed out
that persons working in such industries are exposed to a
mixture ofdifferent metals. Itai-Itai disease represents a
particularly severe manifestation ofchronic cadmium poi-
soning and was observed in several hundreds of middle-
aged women in a Japanese village near Toyama. This
intoxication resulted from the ingestion of rice irrigated
with water contaminated with cadmium, originating from
azincmine. Inaddition topossiblesynergism, theincrease
intheyield ofstructural aberrationscould alsoresultfrom
thefactthatmostofthepatientsreceivedheavyradiodiag-
nostic exposures and various drugs.
Chromium
The behavior of chromium in the organism is greatly
influencedbyitsoxidation state.Thehexavalentchromium
(e.g., chromate) can readily cross cell membranes and is
well absorbed byinhalation orthe oral route, whereas the
trivalent ion hardly moves across cell membranes and is
poorly absorbed. Inside the cell, hexavalent chromium is
reduced to trivalent chromium. The Cr3+ ion trapped
intracellularly canthen reactwith targetmolecules andin
particular with DNA (47). Since the first cases of lung
cancers among workers in chromate-producing industry
reported around the 1930s, several epidemiological sur-
veys confirmed the existence of an increased risk oflung
cancer in chromate-production workers and, to a lesser
extent, in workers from the chrome-pigment industry.
Experiments on laboratory animals showed that the car-
cinogenicity of chromium depends on the oxidative state
and the solubility of the compounds. The most active
compounds seem to be the less water-soluble hexavalent
derivatives (e.g., CaCrO4, ZnCrO4).
Determination ofChromium. Absorbed chromium is
rapidly eliminated in urine with biological half-times
ranging from 15 to 41 hr (48). The concentration ofchro-
mium in urine is a reliable index ofthe recent exposure to
soluble, hexavalent chromium salts. In the presence of
poorly soluble chromium compounds, significant amounts
of chromium may be deposited in the respiratory tract
without necessarily producing elevated levels in urine or
plasma.
It is well established that chromium accumulates in
human lung with age, whereas it decreases in orther
organs [e.g., kidney (49)]. The concentration ofchromium
in lung tissue, normally lower than 1 ppm (wet weight),
may reach very high values in occupationally exposed
persons. Forinstance,valuesrangingfrom58to1400ppm
have been reported in chromium-refining or plating
workers (50). The chromium concentration in lung tissue
may thus serve as a quantitative indicator ofthe previous
exposure. Theconcentration inlungtissueis animportant
criterion for establishing a causal link between bronchial
carcinomaandoccupationalexposure tocertainchromium
compounds.
Because there is a marked difference between tri- and
hexavalent chromium compounds in their ability to cross
cellular membranes, the determination of chromium in
erythrocytes has been proposed to specifically evaluate
the exposure to hexavalent forms of chromium which are
the most hazardous for man (47,48). This method also
presentstheadvantageofintegratingthechromiumexpo-
sure over the life span oferythrocytes (about 100 days).
Cytogenetic Observations on Somatic Cells. Hex-
avalent chromium has been shown to display clastogenic
properties in vitro in mammalian cells and in vivo in
laboratoryanimals,whereastrivalentchromiumappeared
generally inactive (51). The positive results reported by
Bigalievetal. (52) andAzhajev (53) onworkersengagedin
chrome production has not been confirmed, however, by
Husgafvel-Pursiainen etal. (54) and Littorin et al. (55) for
stainless-steelmanualmetal arcweldersexposedtofumes
containing chromium (III) and nickel. In the study of
Littorin et al. (55), the mean exposure time was 19 years,
the air chromium level averaged 81 pLg/m3 at the time of
exposure, and the urinary chromium was 47 ,umole/mole
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creatinine, but, in spite of the high level of exposure, the
yields ofstructural chromosome aberrations and ofmicro-
nucleiorsisterchromatid exchangeswerenotsignificantly
differentfromthevalues foundinthematched controls. In
the three studies, structural chromosome aberrations
were observed after a culture time of 72 hr, and the
number of cells examined was relatively low. It is of
interest to point out that a chromosomal study reported
recentlybySbrana et al. (56) showed onlyaweakincrease
in aberrant cells ofworkers directly exposed to chromite,
which was nonsignificant using different statistical
methods.
Nickel
The carcinogenicity of nickel is well documented.
Experimental studies in laboratory animals indicate that
nickel compounds insoluble in water display high carcino-
genic potential, whereas the majority of soluble nickel
salts seem to be devoid of carcinogenic properties. A
marked increase in cancers of the lung and the nasal
sinuses has been observed in workers at nickel refineries.
Once absorbed, nickel is rapidly eliminated with an
urinary elimination half-time ranging from 17 to 53 hr
(57,58). Observations in retired workers indicate, however,
the existence ofnickel storage deposits with longer elim-
ination half-times (58). Like chromium, nickel accumulates
in lung with age (49).
DeterminationofNickel. Forsolublenickelcompounds
(e.g., NiCl2, NiSO4) the concentrations ofnickel inurine or
plasma reflect the amount of nickel absorbed during the
preceding days (i.e. recent exposure) and are usually
related to the airbone concentrations of the metal. In
adultswithoutoccupational exposure, thelevelsofnickelin
urine and in plasma are usually below 2 ptg/g creatinine
and 0.05 pLg/100 mL, respectively (Table 1).
Poorly soluble nickel compounds (e.g., Ni3S2, NiO), like
chromium compounds, may form deposits in the respira-
tory tract without necessarily increasing the nickel con-
centrationsinurine orplasma. Undertheseconditions, the
lack ofelevatedvalues inurine orplasma does notindicate
the absence ofhealth risk. The amount ofnickel deposited
in the upper respiratory tract may, however, be estimated
by measuring the nickel concentration in the nasal
mucosa. This may be useful, for instance, to confirm
previous exposure in retired workers who have developed
nasal carcinoma (58).
Cytogenetic Observations on Somatic Cells. Some
observations have been made by Boysen et al. (59) and
Waksvick et al. (60,61) on subjects working in nickel
refineries at Falconbridge Nikkelverk, Kristiansand, Nor-
way. In this plant the converter matte (50% Ni, 30% Cu,
20% S, and some trace metals) is refined through several
processes, including crushing, roasting, smelting, and
electrotysis. A total of100 cells per person were analyzed
for the presence of structural aberrations after 48 hr of
culture. The plasma concentrations of nickel averaged 1-
5.2 Rg/L. The results revealed a drastic increase in the
frequency ofgaps among the workers, whereas there was
only a slight enhancement ofbreaks. These positive find-
ings were confirmed later (61) by observing an increase in
gaps and breaks in retired workers with more than 25
years of nickel exposure. The yield of SCEs was not
modified when compared to control values.
Conclusions
Theresults oftheobservationsperformed onperipheral
bloodlymphocytes ofpeople professionally or accidentally
exposed to heavy metals very often appear contradictory,
and methodological features as well as the levels ofintox-
ication cannot explain the differences obtained for people
exposed under comparable conditions. Furthermore, the
observations on peripheral blood lymphocytes frequently
disagree with the properties revealed by the different
heavymetalsinthe invitro assays and in the experiments
on laboratory animals.
Compared to powerful clastogenic agents such as ioniz-
ing radiation, metals have a limited ability to induce
structural aberrations. The nature of the aberrations
observed indicates that metal salts displaying clastogenic
properties cannot be considered as S-independent agents
because the most common aberrations are gaps and
chromatid-type aberrations. Furthermore, the yield of
aberrations is always low in spite ofthe fact that in vitro
systemsimplyexposure to high concentrations ofthe salts
and that in the in vivo experiments laboratory animals
were treated with acute sublethal doses or submitted to
chronicexposureforlongperiods oftime. Exceptforcases
with very high intoxication, it is therefore hard to believe
that chronic exposures to low doses of weak clastogenic
S-dependent agents could enhance the yield ofstructural
chromosome aberrations detectable in a sample of50-200
cells, representing only a very small fraction of the cell
population which has been exposed.
The SCEs observed after culture of peripheral blood
lymphocytes from persons exposed to chemicals are gen-
erallyconsidered the result ofdamageproduced in vivo to
genetic material. Therefore, one cannot exclude the pos-
sibility that the level of exposure in the in vivo studies
performed up to nowwas too low to induce such changes.
Thefactthatsome studies reported forthe samepeoplean
increase ofstructural aberrations with the absence ofany
increase in SCEs may be interpreted as the evidence that
these chromosome anomalies originate from other
environmental agents.
Most people are exposed not to a single metal but to a
mixture ofenvironmentalmutagenicagents. Itistherefore
extremely difficult to establish a causal relationship
between a low increase in chromosome aberrations and
one of the many components encountered in the environ-
ment because these agents may interfere with each other
to produce synergistic or antagonistic effects. Therefore,
the only conclusion that can be drawn from such studies is
thattheworkingconditions encounteredin agivenplantor
workplace have or have not led to an increase in aberra-
tions in the peripheral blood lymphocytes of exposed
subjects. The value of such studies would be greatly
improved byadopting a carefulmethodology, byanalyzing
alargernumberofcells, andbyusingappropriatecontrols.
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The determination of the metal in blood or urine cur-
rently appears the most suitable biological method for
monitoring exposure to carcinogenic metals. The con-
centration ofthemetalinbiologicalfluids orexcretacanbe
measured with great accuracy andprecision, andinterna-
tional programs for quality assurance are available. One
must, however, realize that when determined in blood or
urine, the concentration ofthemetal isusually anindication
ofrecent exposure. Anotherlimitationisthatthesemethods
provide no information on the interaction ofthe metal with
DNA in target tissues. Only an indirect assessment ofthe
probability of such an interaction can be envisaged by
referring to the maximumpermissible value established for
the analyzedmedium. Butthelatterarerarelyderivedfrom
quantitative relationships between themeasured concentra-
tion and the risk ofcarcinogenicity so that such an assess-
ment maybe tainted with much uncertainty.
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